CMS opens Medicare GLP-1 Bridge with $50 monthly copay from July 1
The demonstration runs through December 31, 2027 and covers Zepbound KwikPen, Lilly's oral Foundayo and Novo Nordisk's Wegovy for eligible Part D members.
DO
By Daniel Okafor · Regulatory Correspondent
Jun 27 03:00 ETSource: TIKR.com
The wire
- 01CMS launches the Medicare GLP-1 Bridge on July 1, 2026, giving eligible Part D members certain weight-loss drugs at a flat $50 monthly copay that does not rise with maintenance dose.
- 02Medicare has historically excluded weight-loss drugs, so this is a new coverage channel; one estimate cited puts potentially qualifying Part D beneficiaries at roughly 14 million.
- 03The program is industry-wide rather than manufacturer-specific, and the qualifying-patient figure is a third-party estimate; uptake and pharmacy workflow details remain unclear.
From the source
Read at tikr.comEli Lilly Stock Jumps 7% as Medicare Opens GLP-1 Access: What a $2,100 Target Means for Investors
Eli Lilly and Company ( LLY ) spent most of 2026 fighting a single bearish idea: that the government would squeeze GLP-1 pricing until the growth math stopped working. On June 26, the government moved in a way that cut against that fear. Lilly stock closed up 7.13% at $1,208.12, its best single session in months, after two pieces of news landed within hours of each other. The market had been braci